Previous Close | 0.6782 |
Open | 0.6400 |
Bid | 0.6345 x 800 |
Ask | 0.6400 x 1200 |
Day's Range | 0.6045 - 0.6599 |
52 Week Range | 0.4850 - 50.4000 |
Volume | |
Avg. Volume | 10,789,835 |
Market Cap | 19.992M |
Beta (5Y Monthly) | 1.22 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -26.1610 |
Earnings Date | Aug 11, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for AGRX
Live Conference Call and Webcast at 4:30 p.m. ETPRINCETON, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report second quarter 2022 financial results after the market close on Thursday, August 11, 2022. Following the release, the Company will host a live conference call and webcast at 4:30 p.m. ET to discuss the Company’s financial results and provide a business update. DateThursday, August 11, 2022Time4:30
Maxim Group upgraded Agile Therapeutics Inc (NASDAQ: AGRX) to Buy from Hold with a price target of $1, saying it should be better positioned to begin to rebound. Agile recently closed an equity offering, raising around $24 million in gross proceeds, and brought in around $12.8 million from its ATM facility. The cash runway should be sufficient into 1Q23. In addition, management is enacting austerity measures and refining its commercial efforts, Maxim notes. Related: HC Wainwright Sees Agile Ther
In this article, we discuss the 10 best penny stocks to buy in July. If you want to see only the absolute top penny stocks to buy this month, check out 5 Best Penny Stocks to Buy in July. Penny stocks are priced under $5 and often represent high-risk public companies that do offer exponential […]